弁膜疾患の非薬物治療に関するガイドライン（2012年改訂版）
Guidelines for Surgical and Interventional Treatment of Valvular Haert Disease（ JCS 2012）
文献
401. Meyers PM, Schumacher HC, Higashida RT, et al. Indications for the performance of intracranial endovascular neurointerventional procedures: a
scientific statement from the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular
Surgery and Anesthesia, Interdisciplinary Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes
Research. Circulation 2009; 119: 2235-2249.
402. Blauth CI, Cosgrove DM, Webb BW, et al. Atheroembolism from the ascending aorta. An emerging problem in cardiac surgery. J Thorac Cardiovasc
Surg 1992; 103: 1104-1111.
403. Marshall WG, Jr., Barzilai B, Kouchoukos NT, et al. Intraoperative ultrasonic imaging of the ascending aorta. Ann Thorac Surg 1989; 48: 339-344.
404. Ohteki H, Itoh T, Natsuaki M, et al. Intraoperative ultrasonic imaging of the ascending aorta in ischemic heart disease. Ann Thorac Surg 1990; 50:
539-542.
405. Mills NL, Everson CT. Atherosclerosis of the ascending aorta and coronary artery bypass. Pathology, clinical correlates, and operative management.
J Thorac Cardiovasc Surg 1991; 102: 546-553.
406. Wareing TH, Davila-Roman VG, Barzilai B, et al. Management of the severely atherosclerotic ascending aorta during cardiac operations. A strategy for
detection and treatment. J Thorac Cardiovasc Surg 1992; 103: 453-462.
407. Baribeau YR, Westbrook BM, Charlesworth DC, et al. Arterial inflow via an axillary artery graft for the severely atheromatous aorta. Ann Thorac Surg
998; 66: 33-37.
408. Sabik JF, Lytle BW, McCarthy PM, et al. Axillary artery: an alternative site of arterial cannulation for patients with extensive aortic and peripheral
vascular disease. J Thorac Cardiovasc Surg 1995; 109: 885-890.
409. Coselli JS, Crawford ES. Aortic valve replacement in the patient with extensive calcification of the ascending aorta (the porcelain aorta). J Thorac
Cardiovasc Surg 1986; 91: 184-187.
410. Takami Y, Tajima K, Terazawa S, et al. Safer aortic crossclamping during short-term moderate hypothermic circulatory arrest for cardiac surgery in
patients with a bad ascending aorta. J Thorac Cardiovasc Surg 2009; 137: 875-880.
411. Girardi LN, Krieger KH, Mack CA, et al. No-clamp technique for valve repair or replacement in patients with a porcelain aorta. Ann Thorac Surg 2005;
80: 1688-1692.
412. Markowitz A. Utility of the full root bioprosthesis in surgery for complex aortic valve-ascending aortic disease. Semin Thorac Cardiovasc Surg 2001;
13(4 Suppl 1): 12-15.
413. Ota T, Tsukube T, Matsuda H, et al. Effect of mitral valve surgery on severely impaired pulmonary function. Thorac Cardiovasc Surg 1994; 42: 94-99.
414. Vaidya R, Husain T, Ghosh PK. Spirometric changes after open mitral surgery. J Cardiovasc Surg (Torino) 1996; 37: 295-300.
415. Ohno K, Nakahara K, Hirose H, et al. Effects of valvular surgery on overall and regional lung function in patients with mitral stenosis. Chest 1987; 92:
224-228.
416. Kawazoe K, Beppu S, Takahara Y, et al. Surgical treatment of giant left atrium combined with mitral valvular disease. Plication procedure for reduction
of compression to the left ventricle, bronchus, and pulmonary parenchyma. J Thorac Cardiovasc Surg 1983; 85: 885-892.
417. Sakane M, Ishimitsu T, Ninomiya H, et al. Inhaled nitric oxide in patients with pulmonary hypertension due to valvular heart disease and chronic lung
disease. Jpn Circ J 1998; 62: 877-882.
418. Diez C, Koch D, Kuss O, et al. Risk factors for mediastinitis after cardiac surgery - a retrospective analysis of 1700 patients. J Cardiothorac Surg
2007; 2: 23.
419. Gualis J, Florez S, Tamayo E, et al. Risk factors for mediastinitis and endocarditis after cardiac surgery. Asian Cardiovasc Thorac Ann 2009; 17:
612-616.
420. Adabag AS, Wassif HS, Rice K, et al. Preoperative pulmonary function and mortality after cardiac surgery. Am Heart J 2010; 159: 691-697.
421. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary
disease. N Engl J Med 2004; 350: 1005-1012.
422. Haeffener MP, Ferreira GM, Barreto SS, et al. Incentive spirometry with expiratory positive airway pressure reduces pulmonary complications,
improves pulmonary function and 6-minute walk distance in patients undergoing coronary artery bypass graft surgery. Am Heart J 2008; 156: 900.
423. Urell C, Emtner M, Hedenstrom H, et al. Deep breathing exercises with positive expiratory pressure at a higher rate improve oxygenation in the early
period after cardiac surgery--a randomised controlled trial. Eur J Cardiothorac Surg 2011; 40: 162-167.
424. Utley JR, Leyland SA, Edmunds LH. Preoperative evaluation. In: Edmunds LH editor. Cardiac Surgery in the Adult., McGraw-Hill Company 1997:
145-164.
425. Mangano CM, Diamondstone LS, Ramsay JG, et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital
resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 1998; 128: 194-203.
426. Mehta RH, Grab JD, O’Brien SM, et al. Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. Circulation
2006; 114: 2208-2216.
427. Coca SG, Jammalamadaka D, Sint K, et al. Preoperative proteinuria predicts acute kidney injury in patients undergoing cardiac surgery. J Thorac
Cardiovasc Surg 2012; 143: 495-502.
428. Matsuda H, Hirose H, Nakano S, et al. Results of open heart surgery in patients with impaired renal function as creatinine clearance below 30 ml/min.
The effects of pulsatile perfusion. J Cardiovasc Surg (Torino) 1986; 27: 595-599.
429. Sezai A, Hata M, Niino T, et al. Results of low-dose human atrial natriuretic peptide infusion in nondialysis patients with chronic kidney disease
undergoing coronary artery bypass grafting: the NU-HIT (Nihon University working group study of low-dose HANP Infusion Therapy during cardiac surgery)
trial for CKD. J Am Coll Cardiol 2011; 58: 897-903.
430. Onorati F, Presta P, Fuiano G, et al. A randomized trial of pulsatile perfusion using an intra-aortic balloon pump versus nonpulsatile perfusion on short
-term changes in kidney function during cardiopulmonary bypass during myocardial reperfusion. Am J Kidney Dis 2007; 50: 229-238.
431. Presta P, Onorati F, Fuiano L, et al. Can pulsatile cardiopulmonary bypass prevent perioperative renal dysfunction during myocardial revascularization
in elderly patients? Nephron Clin Pract 2009; 111: c229-c235.
432. Brienza N, Giglio MT, Marucci M, et al. Does perioperative hemodynamic optimization protect renal function in surgical patients? A meta-analytic
study. Crit Care Med 2009; 37: 2079-2090.
433. Bittrick J, D’Cruz IA, Wall BM, et al. Differences and similarities between patients with and without end-stage renal disease, with regard to location of
intracardiac calcification. Echocardiography 2002; 19: 1-6.
434. Frenken M, Krian A. Cardiovascular operations in patients with dialysis-dependent renal failure. Ann Thorac Surg 1999; 68: 887-893.
435. Herzog CA, Ma JZ, Collins AJ. Long-term survival of dialysis patients in the United States with prosthetic heart valves: should ACC/AHA practice
guidelines on valve selection be modified? Circulation 2002; 105: 1336-1341.
436. Horst M, Mehlhorn U, Hoerstrup SP, et al. Cardiac surgery in patients with end-stage renal disease: 10-year experience. Ann Thorac Surg 2000; 69:
96-101.
437. Kaplon RJ, Cosgrove DM, III, Gillinov AM, et al. Cardiac valve replacement in patients on dialysis: influence of prosthesis on survival. Ann Thorac Surg
2000; 70: 438-441.
438. Ura M, Sakata R, Nakayama Y, et al. Bileaflet mechanical valve (St. Jude Medical valve) replacement in long-term dialysis patients. Ann Thorac Surg
1999; 68: 870-873.
439. Thourani VH, Sarin EL, Kilgo PD, et al. Short- and longterm outcomes in patients undergoing valve surgery with endstage renal failure receiving
chronic hemodialysis. J Thorac Cardiovasc Surg 2011.
440. Tanaka K, Tajima K, Takami Y, et al. Early and late outcomes of aortic valve replacement in dialysis patients. Ann Thorac Surg 2010; 89: 65-70.
441. Chan V, Chen L, Mesana L, et al. Heart valve prosthesis selection in patients with end-stage renal disease requiring dialysis: a systematic review and
meta-analysis. Heart 2011; 97: 2033-2037.
442. Kobayashi Y, Fukushima N, Ohtake S, et al. Cardiac surgery in renal transplant recipients. Transplant Proc 1998; 30: 3050-3052.
443. Hill DM, Warren SE, Mitas JA, et al. Hepatic coma after open heart surgery. South Med J 1980; 73: 906-908, 911.
444. Jenkins JG, Lynn AM, Wood AE, et al. Acute hepatic failure following cardiac operation in children. J Thorac Cardiovasc Surg 1982; 84: 865-871.
445. Yamaguchi T, Sawa Y, Masai T, et al. Hepatic sinusoid endothelial dysfunction plays a role in hyperbilirubinemia in patients following implantation
an LVAD. ASAIO J 1997; 43: M449-M452.
446. Lockey E, McIntyre N, Ross DN, et al. Early jaundice after open-heart surgery. Thorax 1967; 22: 165-169.
447. Child CG. Portal Hypertension, WB Saunders 1974.
448. Hirata N, Sawa Y, Matsuda H. Predictive value of preoperative serum cholinesterase concentration in patients with liver dysfunction undergoing cardiac
surgery. J Card Surg 1999; 14: 172-177.
449. 阪越信雄，川副浩平，鬼頭義次，他．開心術後高度肝機能障害における危険因子の臨床的検討．日胸外会誌 1987; 35: 42-48.
450. Kaplan M, Cimen S, Kut MS, et al. Cardiac operations for patients with chronic liver disease. Heart Surg Forum 2002; 5: 60-65.
451. Forman LM, Lucey MR. Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo End-stage Liver Disease. Hepatology
2001; 33: 473-475.
452. Modi A, Vohra HA, Barlow CW. Do patients with liver cirrhosis undergoing cardiac surgery have acceptable outcomes? Interact Cardiovasc Thorac
Surg 2010; 11: 630-634.
453. Misawa S, Aizawa K, Kaminishi Y, et al. Starr-Edwards valves at the aortic and mitral positions implanted for 39 years. Gen Thorac Cardiovasc Surg
2011; 59: 433-435.
454. Aoyagi S, Fukunaga S, Arinaga K. Disc wear and entrapment in a Starr-Edwards mitral caged-disc valve. J Heart Valve Dis 2011; 20: 474-476.
455. Bernet FH, Baykut D, Grize L, et al. Single-center outcome analysis of 1,161 patients with St. Jude medical and ATS open pivot mechanical heart
valves. J Heart Valve Dis 2007; 16: 151-158.
456. Emery RW, Krogh CC, Arom KV, et al. The St. Jude Medical cardiac valve prosthesis: a 25-year experience with single valve replacement. Ann
Thorac Surg 2005; 79: 776-782.
457. Aagaard J, Tingleff J. Fifteen years’ clinical experience with the CarboMedics prosthetic heart valve. J Heart Valve Dis 2005; 14: 82-88.
458. Tominaga R, Kurisu K, Ochiai Y, et al. A 10-year experience with the Carbomedics cardiac prosthesis. Ann Thorac Surg 2005; 79: 784-789.
459. Azarnoush K, Laborde F, de RC. The Sorin Bicarbon over 15 years clinical outcomes: multicentre experience in 1704 patients. Eur J Cardiothorac
Surg 2010; 38: 759-766.
460. Sezai A, Hata M, Niino T, et al. Fifteen years of experience with ATS mechanical heart valve prostheses. J Thorac Cardiovasc Surg 2010; 139:
1494-1500.
461. Tossios P, Reber D, Oustria M, et al. Single-center experience with the On-X prosthetic heart valve between 1996 and 2005. J Heart Valve Dis 2007;
16: 551-557.
462. Edmunds LH, Jr., Clark RE, Cohn LH, et al. Guidelines for reporting morbidity and mortality after cardiac valvular operations. The American
Association for Thoracic Surgery, Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity. Ann Thorac Surg 1996;
62: 932-935.
463. Edmunds LH, Clark RE, Chon LH, et al. Guirdlines for reporting morbidity and mortality after cardiac valvular operations. J Thorac Cradiovasc Surg
1996; 112: 708-711.
464. 循環器病の診断と治療に関するガイドライン．循環器疾患における抗凝固・抗血小板療法に関するガイドライン（2009年改訂版）．
http://www.j-circ.or.jp/guideline/pdf/JCS2009_hori_h.pdf
465. Hirsh J, Fuster V. Guide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association. Circulation 1994; 89: 1469-1480.
466. Turpie AG. Safer anticoagulant therapy after heart valve replacement. Recommendations for less intense regimens. Postgrad Med 1997; 101: 85-90,
93.
467. Acar J, Iung B, Boissel JP, et al. AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with
mechanical prosthetic heart valves. Circulation 1996; 94: 2107-2112.
468. Altman R, Rouvier J, Gurfinkel E, et al. Comparison of two levels of anticoagulant therapy in patients with substitute heart valves. J Thorac Cardiovasc
Surg 1991; 101: 427-431.
469. Butchart EG, Lewis PA, Grunkemeier GL, et al. Low risk of thrombosis and serious embolic events despite lowintensity anticoagulation. Experience
with 1,004 Medtronic Hall valves. Circulation 1988; 78(3 Pt 2): I66-I77.
470. Horstkotte D, Schulte HD, Bircks W, et al. Lower intensity anticoagulation therapy results in lower complication rates with the St. Jude Medical
prosthesis. J Thorac Cardiovasc Surg 1994; 107: 1136-1145.
471. Horstkotte D, Schulte H, Bircks W, et al. Unexpected findings concerning thromboembolic complications and anticoagulation after complete 10 year
follow up of patients with St. Jude Medical prostheses. J Heart Valve Dis 1993; 2: 291-301.
472. Saour JN, Sieck JO, Mamo LA, et al. Trial of different intensities of anticoagulation in patients with prosthetic heart valves. N Engl J Med 1990; 322:
428-432.
473. Guyatt GH, Akl EA, Crowther M, et al. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest
Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(2 Suppl): 7S-47S.
474. Ratnatunga CP, Edwards MB, Dore CJ, et al. Tricuspid valve replacement: UK Heart Valve Registry mid-term results comparing mechanical and
biological prostheses. Ann Thorac Surg 1998; 66: 1940-1947.
475. Filsoufi F, Anyanwu AC, Salzberg SP, et al. Long-term outcomes of tricuspid valve replacement in the current era. Ann Thorac Surg 2005;
80: 845-850.
476. Kitamura M, Koyanagi H, Kawada S, et al. Optimum anticoagulation control after bileaflet mechanical valve replacement: a prospective multi
-institutional study. Kyobu Geka 1999; 52: 1001-1004.
477. Kobayashi Y, Eishi K, Nagata S, et al. Choice of replacement valve in the elderly. J Heart Valve Dis 1997; 6: 404-409.
478. Matsuyama K, Matsumoto M, Sugita T, et al. Anticoagulant therapy in Japanese patients with mechanical mitral valves. Circ J 2002; 66: 668-670.
479. Soga Y, Okabayashi H, Nishina T, et al. Up to 8-year follow-up of valve replacement with carbomedics valve. Ann Thorac Surg 2002; 73: 474-479.
480. Albertal J, Sutton M, Pereyra D, et al. Experience with moderate intensity anticoagulation and aspirin after mechanical valve replacement. A
retrospective, nonrandomized study. J Heart Valve Dis 1993; 2: 302-307.
481. Chesebro JH, Fuster V, Elveback LR, et al. Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement:
danger of aspirin compared with dipyridamole. Am J Cardiol 1983; 51: 1537-1541.
482. Hayashi J, Nakazawa S, Oguma F, et al. Combined warfarin and antiplatelet therapy after St. Jude Medical valve replacement for mitral valve disease.
J Am Coll Cardiol 1994; 23: 672-677.
483. Meschengieser SS, Fondevila CG, Frontroth J, et al. Lowintensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation
alone: a randomized trial in patients with mechanical prosthetic heart valves. J Thorac Cardiovasc Surg 1997; 113: 910-916.
484. Turpie AG, Gent M, Laupacis A, et al. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J
Med 1993; 329: 524-529.
485. Heras M, Chesebro JH, Fuster V, et al. High risk of thromboemboli early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol 1995; 25:
1111-1119.
486. Gohlke-Barwolf C, Acar J, Oakley C, et al. Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working
Group on Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 1995; 16: 1320-1330.
487. Wahl MJ. Dental surgery in anticoagulated patients. Arch Intern Med 1998; 158: 1610-1616.
488. 矢坂正弘, 木村和美, 峰松一夫. ワルファリン療法中に発症した脳梗塞の検討. 老年医誌 2003; 40(Supple): 122.
489. Devani P, Lavery KM, Howell CJ. Dental extractions in patients on warfarin: is alteration of anticoagulant regime necessary? Br J Oral Maxillofac Surg
1998; 36: 107-111.
490. Evans IL, Sayers MS, Gibbons AJ, et al. Can warfarin be continued during dental extraction? Results of a randomized controlled trial. Br J Oral
Maxillofac Surg 2002; 40: 248-252.
491. Loeliger EA, Broekmans AW. Optimal therapeutic anticoagulation. Haemostasis 1985; 15: 283-292.
492. 青崎正彦，岩出和徳．抗凝血薬・抗血小板薬を服用中の患者に外科的処置をするには．JIM 1993; 23: 419-421.
493. 藤本耕二，菅原利夫，高橋俊幸．ワルファリンによる抗凝固療法中の患者に対する口腔外科的処置．阪大歯学雑誌1995; 40: 400-404.
494. 北村龍二，肇 鏡，平沼 勉．ワーファリン服用患者の抜歯．非中止症例の検討．日口外誌 2001; 47: 1096.
495. 金田敏郎．血液凝固異常患者の歯科治療．日歯医師会誌1993; 46: 567-572.
496. 藤喜久夫．介護保険と病診連携．大歯会誌 2000; 596:2-14.
497. Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med 1997; 336: 1506-1511.
498. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation 1997;
96: 358-366.
499. Lip GY, Frison L, Halperin JL, et al. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial
fibrillation: the HASBLED(Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol
Concomitantly) score. J Am Coll Cardiol 2011; 57: 173-180.
500. Bloomfield P, Wheatley DJ, Prescott RJ, et al. Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. N Engl
J Med 1991; 324: 573-579.
scientific statement from the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular
Surgery and Anesthesia, Interdisciplinary Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes
Research. Circulation 2009; 119: 2235-2249.
402. Blauth CI, Cosgrove DM, Webb BW, et al. Atheroembolism from the ascending aorta. An emerging problem in cardiac surgery. J Thorac Cardiovasc
Surg 1992; 103: 1104-1111.
403. Marshall WG, Jr., Barzilai B, Kouchoukos NT, et al. Intraoperative ultrasonic imaging of the ascending aorta. Ann Thorac Surg 1989; 48: 339-344.
404. Ohteki H, Itoh T, Natsuaki M, et al. Intraoperative ultrasonic imaging of the ascending aorta in ischemic heart disease. Ann Thorac Surg 1990; 50:
539-542.
405. Mills NL, Everson CT. Atherosclerosis of the ascending aorta and coronary artery bypass. Pathology, clinical correlates, and operative management.
J Thorac Cardiovasc Surg 1991; 102: 546-553.
406. Wareing TH, Davila-Roman VG, Barzilai B, et al. Management of the severely atherosclerotic ascending aorta during cardiac operations. A strategy for
detection and treatment. J Thorac Cardiovasc Surg 1992; 103: 453-462.
407. Baribeau YR, Westbrook BM, Charlesworth DC, et al. Arterial inflow via an axillary artery graft for the severely atheromatous aorta. Ann Thorac Surg
998; 66: 33-37.
408. Sabik JF, Lytle BW, McCarthy PM, et al. Axillary artery: an alternative site of arterial cannulation for patients with extensive aortic and peripheral
vascular disease. J Thorac Cardiovasc Surg 1995; 109: 885-890.
409. Coselli JS, Crawford ES. Aortic valve replacement in the patient with extensive calcification of the ascending aorta (the porcelain aorta). J Thorac
Cardiovasc Surg 1986; 91: 184-187.
410. Takami Y, Tajima K, Terazawa S, et al. Safer aortic crossclamping during short-term moderate hypothermic circulatory arrest for cardiac surgery in
patients with a bad ascending aorta. J Thorac Cardiovasc Surg 2009; 137: 875-880.
411. Girardi LN, Krieger KH, Mack CA, et al. No-clamp technique for valve repair or replacement in patients with a porcelain aorta. Ann Thorac Surg 2005;
80: 1688-1692.
412. Markowitz A. Utility of the full root bioprosthesis in surgery for complex aortic valve-ascending aortic disease. Semin Thorac Cardiovasc Surg 2001;
13(4 Suppl 1): 12-15.
413. Ota T, Tsukube T, Matsuda H, et al. Effect of mitral valve surgery on severely impaired pulmonary function. Thorac Cardiovasc Surg 1994; 42: 94-99.
414. Vaidya R, Husain T, Ghosh PK. Spirometric changes after open mitral surgery. J Cardiovasc Surg (Torino) 1996; 37: 295-300.
415. Ohno K, Nakahara K, Hirose H, et al. Effects of valvular surgery on overall and regional lung function in patients with mitral stenosis. Chest 1987; 92:
224-228.
416. Kawazoe K, Beppu S, Takahara Y, et al. Surgical treatment of giant left atrium combined with mitral valvular disease. Plication procedure for reduction
of compression to the left ventricle, bronchus, and pulmonary parenchyma. J Thorac Cardiovasc Surg 1983; 85: 885-892.
417. Sakane M, Ishimitsu T, Ninomiya H, et al. Inhaled nitric oxide in patients with pulmonary hypertension due to valvular heart disease and chronic lung
disease. Jpn Circ J 1998; 62: 877-882.
418. Diez C, Koch D, Kuss O, et al. Risk factors for mediastinitis after cardiac surgery - a retrospective analysis of 1700 patients. J Cardiothorac Surg
2007; 2: 23.
419. Gualis J, Florez S, Tamayo E, et al. Risk factors for mediastinitis and endocarditis after cardiac surgery. Asian Cardiovasc Thorac Ann 2009; 17:
612-616.
420. Adabag AS, Wassif HS, Rice K, et al. Preoperative pulmonary function and mortality after cardiac surgery. Am Heart J 2010; 159: 691-697.
421. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary
disease. N Engl J Med 2004; 350: 1005-1012.
422. Haeffener MP, Ferreira GM, Barreto SS, et al. Incentive spirometry with expiratory positive airway pressure reduces pulmonary complications,
improves pulmonary function and 6-minute walk distance in patients undergoing coronary artery bypass graft surgery. Am Heart J 2008; 156: 900.
423. Urell C, Emtner M, Hedenstrom H, et al. Deep breathing exercises with positive expiratory pressure at a higher rate improve oxygenation in the early
period after cardiac surgery--a randomised controlled trial. Eur J Cardiothorac Surg 2011; 40: 162-167.
424. Utley JR, Leyland SA, Edmunds LH. Preoperative evaluation. In: Edmunds LH editor. Cardiac Surgery in the Adult., McGraw-Hill Company 1997:
145-164.
425. Mangano CM, Diamondstone LS, Ramsay JG, et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital
resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 1998; 128: 194-203.
426. Mehta RH, Grab JD, O’Brien SM, et al. Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. Circulation
2006; 114: 2208-2216.
427. Coca SG, Jammalamadaka D, Sint K, et al. Preoperative proteinuria predicts acute kidney injury in patients undergoing cardiac surgery. J Thorac
Cardiovasc Surg 2012; 143: 495-502.
428. Matsuda H, Hirose H, Nakano S, et al. Results of open heart surgery in patients with impaired renal function as creatinine clearance below 30 ml/min.
The effects of pulsatile perfusion. J Cardiovasc Surg (Torino) 1986; 27: 595-599.
429. Sezai A, Hata M, Niino T, et al. Results of low-dose human atrial natriuretic peptide infusion in nondialysis patients with chronic kidney disease
undergoing coronary artery bypass grafting: the NU-HIT (Nihon University working group study of low-dose HANP Infusion Therapy during cardiac surgery)
trial for CKD. J Am Coll Cardiol 2011; 58: 897-903.
430. Onorati F, Presta P, Fuiano G, et al. A randomized trial of pulsatile perfusion using an intra-aortic balloon pump versus nonpulsatile perfusion on short
-term changes in kidney function during cardiopulmonary bypass during myocardial reperfusion. Am J Kidney Dis 2007; 50: 229-238.
431. Presta P, Onorati F, Fuiano L, et al. Can pulsatile cardiopulmonary bypass prevent perioperative renal dysfunction during myocardial revascularization
in elderly patients? Nephron Clin Pract 2009; 111: c229-c235.
432. Brienza N, Giglio MT, Marucci M, et al. Does perioperative hemodynamic optimization protect renal function in surgical patients? A meta-analytic
study. Crit Care Med 2009; 37: 2079-2090.
433. Bittrick J, D’Cruz IA, Wall BM, et al. Differences and similarities between patients with and without end-stage renal disease, with regard to location of
intracardiac calcification. Echocardiography 2002; 19: 1-6.
434. Frenken M, Krian A. Cardiovascular operations in patients with dialysis-dependent renal failure. Ann Thorac Surg 1999; 68: 887-893.
435. Herzog CA, Ma JZ, Collins AJ. Long-term survival of dialysis patients in the United States with prosthetic heart valves: should ACC/AHA practice
guidelines on valve selection be modified? Circulation 2002; 105: 1336-1341.
436. Horst M, Mehlhorn U, Hoerstrup SP, et al. Cardiac surgery in patients with end-stage renal disease: 10-year experience. Ann Thorac Surg 2000; 69:
96-101.
437. Kaplon RJ, Cosgrove DM, III, Gillinov AM, et al. Cardiac valve replacement in patients on dialysis: influence of prosthesis on survival. Ann Thorac Surg
2000; 70: 438-441.
438. Ura M, Sakata R, Nakayama Y, et al. Bileaflet mechanical valve (St. Jude Medical valve) replacement in long-term dialysis patients. Ann Thorac Surg
1999; 68: 870-873.
439. Thourani VH, Sarin EL, Kilgo PD, et al. Short- and longterm outcomes in patients undergoing valve surgery with endstage renal failure receiving
chronic hemodialysis. J Thorac Cardiovasc Surg 2011.
440. Tanaka K, Tajima K, Takami Y, et al. Early and late outcomes of aortic valve replacement in dialysis patients. Ann Thorac Surg 2010; 89: 65-70.
441. Chan V, Chen L, Mesana L, et al. Heart valve prosthesis selection in patients with end-stage renal disease requiring dialysis: a systematic review and
meta-analysis. Heart 2011; 97: 2033-2037.
442. Kobayashi Y, Fukushima N, Ohtake S, et al. Cardiac surgery in renal transplant recipients. Transplant Proc 1998; 30: 3050-3052.
443. Hill DM, Warren SE, Mitas JA, et al. Hepatic coma after open heart surgery. South Med J 1980; 73: 906-908, 911.
444. Jenkins JG, Lynn AM, Wood AE, et al. Acute hepatic failure following cardiac operation in children. J Thorac Cardiovasc Surg 1982; 84: 865-871.
445. Yamaguchi T, Sawa Y, Masai T, et al. Hepatic sinusoid endothelial dysfunction plays a role in hyperbilirubinemia in patients following implantation
an LVAD. ASAIO J 1997; 43: M449-M452.
446. Lockey E, McIntyre N, Ross DN, et al. Early jaundice after open-heart surgery. Thorax 1967; 22: 165-169.
447. Child CG. Portal Hypertension, WB Saunders 1974.
448. Hirata N, Sawa Y, Matsuda H. Predictive value of preoperative serum cholinesterase concentration in patients with liver dysfunction undergoing cardiac
surgery. J Card Surg 1999; 14: 172-177.
449. 阪越信雄，川副浩平，鬼頭義次，他．開心術後高度肝機能障害における危険因子の臨床的検討．日胸外会誌 1987; 35: 42-48.
450. Kaplan M, Cimen S, Kut MS, et al. Cardiac operations for patients with chronic liver disease. Heart Surg Forum 2002; 5: 60-65.
451. Forman LM, Lucey MR. Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo End-stage Liver Disease. Hepatology
2001; 33: 473-475.
452. Modi A, Vohra HA, Barlow CW. Do patients with liver cirrhosis undergoing cardiac surgery have acceptable outcomes? Interact Cardiovasc Thorac
Surg 2010; 11: 630-634.
453. Misawa S, Aizawa K, Kaminishi Y, et al. Starr-Edwards valves at the aortic and mitral positions implanted for 39 years. Gen Thorac Cardiovasc Surg
2011; 59: 433-435.
454. Aoyagi S, Fukunaga S, Arinaga K. Disc wear and entrapment in a Starr-Edwards mitral caged-disc valve. J Heart Valve Dis 2011; 20: 474-476.
455. Bernet FH, Baykut D, Grize L, et al. Single-center outcome analysis of 1,161 patients with St. Jude medical and ATS open pivot mechanical heart
valves. J Heart Valve Dis 2007; 16: 151-158.
456. Emery RW, Krogh CC, Arom KV, et al. The St. Jude Medical cardiac valve prosthesis: a 25-year experience with single valve replacement. Ann
Thorac Surg 2005; 79: 776-782.
457. Aagaard J, Tingleff J. Fifteen years’ clinical experience with the CarboMedics prosthetic heart valve. J Heart Valve Dis 2005; 14: 82-88.
458. Tominaga R, Kurisu K, Ochiai Y, et al. A 10-year experience with the Carbomedics cardiac prosthesis. Ann Thorac Surg 2005; 79: 784-789.
459. Azarnoush K, Laborde F, de RC. The Sorin Bicarbon over 15 years clinical outcomes: multicentre experience in 1704 patients. Eur J Cardiothorac
Surg 2010; 38: 759-766.
460. Sezai A, Hata M, Niino T, et al. Fifteen years of experience with ATS mechanical heart valve prostheses. J Thorac Cardiovasc Surg 2010; 139:
1494-1500.
461. Tossios P, Reber D, Oustria M, et al. Single-center experience with the On-X prosthetic heart valve between 1996 and 2005. J Heart Valve Dis 2007;
16: 551-557.
462. Edmunds LH, Jr., Clark RE, Cohn LH, et al. Guidelines for reporting morbidity and mortality after cardiac valvular operations. The American
Association for Thoracic Surgery, Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity. Ann Thorac Surg 1996;
62: 932-935.
463. Edmunds LH, Clark RE, Chon LH, et al. Guirdlines for reporting morbidity and mortality after cardiac valvular operations. J Thorac Cradiovasc Surg
1996; 112: 708-711.
464. 循環器病の診断と治療に関するガイドライン．循環器疾患における抗凝固・抗血小板療法に関するガイドライン（2009年改訂版）．
http://www.j-circ.or.jp/guideline/pdf/JCS2009_hori_h.pdf
465. Hirsh J, Fuster V. Guide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association. Circulation 1994; 89: 1469-1480.
466. Turpie AG. Safer anticoagulant therapy after heart valve replacement. Recommendations for less intense regimens. Postgrad Med 1997; 101: 85-90,
93.
467. Acar J, Iung B, Boissel JP, et al. AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with
mechanical prosthetic heart valves. Circulation 1996; 94: 2107-2112.
468. Altman R, Rouvier J, Gurfinkel E, et al. Comparison of two levels of anticoagulant therapy in patients with substitute heart valves. J Thorac Cardiovasc
Surg 1991; 101: 427-431.
469. Butchart EG, Lewis PA, Grunkemeier GL, et al. Low risk of thrombosis and serious embolic events despite lowintensity anticoagulation. Experience
with 1,004 Medtronic Hall valves. Circulation 1988; 78(3 Pt 2): I66-I77.
470. Horstkotte D, Schulte HD, Bircks W, et al. Lower intensity anticoagulation therapy results in lower complication rates with the St. Jude Medical
prosthesis. J Thorac Cardiovasc Surg 1994; 107: 1136-1145.
471. Horstkotte D, Schulte H, Bircks W, et al. Unexpected findings concerning thromboembolic complications and anticoagulation after complete 10 year
follow up of patients with St. Jude Medical prostheses. J Heart Valve Dis 1993; 2: 291-301.
472. Saour JN, Sieck JO, Mamo LA, et al. Trial of different intensities of anticoagulation in patients with prosthetic heart valves. N Engl J Med 1990; 322:
428-432.
473. Guyatt GH, Akl EA, Crowther M, et al. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest
Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(2 Suppl): 7S-47S.
474. Ratnatunga CP, Edwards MB, Dore CJ, et al. Tricuspid valve replacement: UK Heart Valve Registry mid-term results comparing mechanical and
biological prostheses. Ann Thorac Surg 1998; 66: 1940-1947.
475. Filsoufi F, Anyanwu AC, Salzberg SP, et al. Long-term outcomes of tricuspid valve replacement in the current era. Ann Thorac Surg 2005;
80: 845-850.
476. Kitamura M, Koyanagi H, Kawada S, et al. Optimum anticoagulation control after bileaflet mechanical valve replacement: a prospective multi
-institutional study. Kyobu Geka 1999; 52: 1001-1004.
477. Kobayashi Y, Eishi K, Nagata S, et al. Choice of replacement valve in the elderly. J Heart Valve Dis 1997; 6: 404-409.
478. Matsuyama K, Matsumoto M, Sugita T, et al. Anticoagulant therapy in Japanese patients with mechanical mitral valves. Circ J 2002; 66: 668-670.
479. Soga Y, Okabayashi H, Nishina T, et al. Up to 8-year follow-up of valve replacement with carbomedics valve. Ann Thorac Surg 2002; 73: 474-479.
480. Albertal J, Sutton M, Pereyra D, et al. Experience with moderate intensity anticoagulation and aspirin after mechanical valve replacement. A
retrospective, nonrandomized study. J Heart Valve Dis 1993; 2: 302-307.
481. Chesebro JH, Fuster V, Elveback LR, et al. Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement:
danger of aspirin compared with dipyridamole. Am J Cardiol 1983; 51: 1537-1541.
482. Hayashi J, Nakazawa S, Oguma F, et al. Combined warfarin and antiplatelet therapy after St. Jude Medical valve replacement for mitral valve disease.
J Am Coll Cardiol 1994; 23: 672-677.
483. Meschengieser SS, Fondevila CG, Frontroth J, et al. Lowintensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation
alone: a randomized trial in patients with mechanical prosthetic heart valves. J Thorac Cardiovasc Surg 1997; 113: 910-916.
484. Turpie AG, Gent M, Laupacis A, et al. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J
Med 1993; 329: 524-529.
485. Heras M, Chesebro JH, Fuster V, et al. High risk of thromboemboli early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol 1995; 25:
1111-1119.
486. Gohlke-Barwolf C, Acar J, Oakley C, et al. Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working
Group on Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 1995; 16: 1320-1330.
487. Wahl MJ. Dental surgery in anticoagulated patients. Arch Intern Med 1998; 158: 1610-1616.
488. 矢坂正弘, 木村和美, 峰松一夫. ワルファリン療法中に発症した脳梗塞の検討. 老年医誌 2003; 40(Supple): 122.
489. Devani P, Lavery KM, Howell CJ. Dental extractions in patients on warfarin: is alteration of anticoagulant regime necessary? Br J Oral Maxillofac Surg
1998; 36: 107-111.
490. Evans IL, Sayers MS, Gibbons AJ, et al. Can warfarin be continued during dental extraction? Results of a randomized controlled trial. Br J Oral
Maxillofac Surg 2002; 40: 248-252.
491. Loeliger EA, Broekmans AW. Optimal therapeutic anticoagulation. Haemostasis 1985; 15: 283-292.
492. 青崎正彦，岩出和徳．抗凝血薬・抗血小板薬を服用中の患者に外科的処置をするには．JIM 1993; 23: 419-421.
493. 藤本耕二，菅原利夫，高橋俊幸．ワルファリンによる抗凝固療法中の患者に対する口腔外科的処置．阪大歯学雑誌1995; 40: 400-404.
494. 北村龍二，肇 鏡，平沼 勉．ワーファリン服用患者の抜歯．非中止症例の検討．日口外誌 2001; 47: 1096.
495. 金田敏郎．血液凝固異常患者の歯科治療．日歯医師会誌1993; 46: 567-572.
496. 藤喜久夫．介護保険と病診連携．大歯会誌 2000; 596:2-14.
497. Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med 1997; 336: 1506-1511.
498. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation 1997;
96: 358-366.
499. Lip GY, Frison L, Halperin JL, et al. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial
fibrillation: the HASBLED(Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol
Concomitantly) score. J Am Coll Cardiol 2011; 57: 173-180.
500. Bloomfield P, Wheatley DJ, Prescott RJ, et al. Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. N Engl
J Med 1991; 324: 573-579.